Cargando…
Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report
BACKGROUND: We present this case to draw attention to the importance of early diagnosis in terms of life-saving, noting that greater awareness is important among healthcare professionals. Our patient developed neuroleptic malignant syndrome (NMS) after his neuroleptic drug dosage was increased. His...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535839/ https://www.ncbi.nlm.nih.gov/pubmed/36203196 http://dx.doi.org/10.1186/s13256-022-03591-5 |
_version_ | 1784802859492048896 |
---|---|
author | Chang, Chee Keong Payus, Alvin Oliver Noh, Malehah Mohd Lansing, Meryl Grace Sumpat, Doreen Lu, Sooth Jiun Andrea Yew, Boon Teong |
author_facet | Chang, Chee Keong Payus, Alvin Oliver Noh, Malehah Mohd Lansing, Meryl Grace Sumpat, Doreen Lu, Sooth Jiun Andrea Yew, Boon Teong |
author_sort | Chang, Chee Keong |
collection | PubMed |
description | BACKGROUND: We present this case to draw attention to the importance of early diagnosis in terms of life-saving, noting that greater awareness is important among healthcare professionals. Our patient developed neuroleptic malignant syndrome (NMS) after his neuroleptic drug dosage was increased. His condition was complicated by acute kidney injury (AKI) which required hemodialysis. The uniqueness of this case is that the causative agent of NMS is an atypical antipsychotic, and atypical antipsychotics are generally considered to be safer than typical antipsychotics. CASE PRESENTATION: A 31-year-old Chinese man with underlying schizophrenia presented to our hospital with aggressive behavior. He was admitted to the psychiatric hospital and started on his regular medications, with an increase in the dose of olanzapine tablet from 5 to 10 mg daily. After 5 days in the ward, the patient was noted to have high fever, restlessness, confusion, increased muscle rigidity, tachycardia and tachypnoea. Antipsychotic therapy was stopped in view of suspected NMS. The first laboratory test for serum creatine kinase (CK) showed a markedly high level of this molecule. His renal profile showed raised serum creatinine in comparison to 2 months prior when the baseline serum creatinine was within the normal range. A diagnosis of NMS with AKI was made. Although the patient was given adequate intravenous fluid hydration with close monitoring of urine output, his renal function did not show improvement but continued to show a worsening trend. In view of this, he was started on urgent hemodialysis. The patient was dependent on intermittent hemodialysis before his AKI showed complete recovery. After 2 weeks, his blood test results returned to normal. He was discharged well. CONCLUSION: Neuroleptic malignant syndrome is a life-threatening iatrogenic medical emergency in which high index of clinical suspicion is required for diagnosis and prompt treatment. |
format | Online Article Text |
id | pubmed-9535839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95358392022-10-07 Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report Chang, Chee Keong Payus, Alvin Oliver Noh, Malehah Mohd Lansing, Meryl Grace Sumpat, Doreen Lu, Sooth Jiun Andrea Yew, Boon Teong J Med Case Rep Case Report BACKGROUND: We present this case to draw attention to the importance of early diagnosis in terms of life-saving, noting that greater awareness is important among healthcare professionals. Our patient developed neuroleptic malignant syndrome (NMS) after his neuroleptic drug dosage was increased. His condition was complicated by acute kidney injury (AKI) which required hemodialysis. The uniqueness of this case is that the causative agent of NMS is an atypical antipsychotic, and atypical antipsychotics are generally considered to be safer than typical antipsychotics. CASE PRESENTATION: A 31-year-old Chinese man with underlying schizophrenia presented to our hospital with aggressive behavior. He was admitted to the psychiatric hospital and started on his regular medications, with an increase in the dose of olanzapine tablet from 5 to 10 mg daily. After 5 days in the ward, the patient was noted to have high fever, restlessness, confusion, increased muscle rigidity, tachycardia and tachypnoea. Antipsychotic therapy was stopped in view of suspected NMS. The first laboratory test for serum creatine kinase (CK) showed a markedly high level of this molecule. His renal profile showed raised serum creatinine in comparison to 2 months prior when the baseline serum creatinine was within the normal range. A diagnosis of NMS with AKI was made. Although the patient was given adequate intravenous fluid hydration with close monitoring of urine output, his renal function did not show improvement but continued to show a worsening trend. In view of this, he was started on urgent hemodialysis. The patient was dependent on intermittent hemodialysis before his AKI showed complete recovery. After 2 weeks, his blood test results returned to normal. He was discharged well. CONCLUSION: Neuroleptic malignant syndrome is a life-threatening iatrogenic medical emergency in which high index of clinical suspicion is required for diagnosis and prompt treatment. BioMed Central 2022-10-06 /pmc/articles/PMC9535839/ /pubmed/36203196 http://dx.doi.org/10.1186/s13256-022-03591-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Chang, Chee Keong Payus, Alvin Oliver Noh, Malehah Mohd Lansing, Meryl Grace Sumpat, Doreen Lu, Sooth Jiun Andrea Yew, Boon Teong Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report |
title | Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report |
title_full | Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report |
title_fullStr | Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report |
title_full_unstemmed | Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report |
title_short | Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report |
title_sort | neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535839/ https://www.ncbi.nlm.nih.gov/pubmed/36203196 http://dx.doi.org/10.1186/s13256-022-03591-5 |
work_keys_str_mv | AT changcheekeong neurolepticmalignantsyndromesecondarytoolanzapineapresentationwithsevereacutekidneyinjuryrequiringhemodialysisacasereport AT payusalvinoliver neurolepticmalignantsyndromesecondarytoolanzapineapresentationwithsevereacutekidneyinjuryrequiringhemodialysisacasereport AT nohmalehahmohd neurolepticmalignantsyndromesecondarytoolanzapineapresentationwithsevereacutekidneyinjuryrequiringhemodialysisacasereport AT lansingmerylgrace neurolepticmalignantsyndromesecondarytoolanzapineapresentationwithsevereacutekidneyinjuryrequiringhemodialysisacasereport AT sumpatdoreen neurolepticmalignantsyndromesecondarytoolanzapineapresentationwithsevereacutekidneyinjuryrequiringhemodialysisacasereport AT lusoothjiunandrea neurolepticmalignantsyndromesecondarytoolanzapineapresentationwithsevereacutekidneyinjuryrequiringhemodialysisacasereport AT yewboonteong neurolepticmalignantsyndromesecondarytoolanzapineapresentationwithsevereacutekidneyinjuryrequiringhemodialysisacasereport |